Chaoyang is the Head of Computation Biology and Bioinformatics at Blueprint Medicines, a precision medicine company focused on oncology and rare genetic diseases. Since completing his PhD in Microbiology, he has been leading technology innovation in the academic, non-profit, pharmaceutical and biotech fields. He co-led the first genomic sequencing of two ant species, established single cell and CRISPR screening to study neurological diseases and invented industrial scale genomics method for in-depth drug profiling. He is passionate about harnessing new technology and big data for better decision making and improving lives.